$CAI News

Caris Life Sciences (CAI) Will Present Seven Studies At A Global Lung Conference

Caris Life Sciences to Present New Research Advancing Precision Oncology at the IASLC 2026 World Conference on Lung Cancer

Caris Life Sciences Publishes npj Precision Oncology Study Showing AI-Guided Therapy Selection is Predictive of Longer Survival in Patients with Pancreatic Cancer

Caris Life Sciences Announces Publication Of Study Validating An AI-Driven Approach To First-Line Treatment Selection In Pancreatic Cancer In The Journal 'npj Precision Oncology'

Caris Life Sciences, Inc. 2026 Q2 - Results - Earnings Call Presentation

What’s Next For Caris Life Sciences (CAI) After 21% Jump?

Caris Life Sciences, ECOG-ACRIN and NRG Oncology Study Demonstrates Multimodal AI Approach to Predict Late Distant Recurrence Risk in HR+ Early Breast Cancer

Caris Life Sciences, Inc. Q2 2026 Earnings Call Summary

Evercore ISI Group Maintains Outperform on Caris Life Sciences, Raises Price Target to $26

Caris Life Sciences Inc (CAI) (Q2 2026) Earnings Call Highlights: Record Revenue and Volume ...

Caris Life Sciences Q2 Earnings Call Highlights

Caris Life Sciences,?Inc. (CAI) Reports Break-Even Earnings for Q2

Caris Life Sciences, Inc. (CAI) Q2 2026 Earnings Call Transcript

Caris Life Sciences Reports Second Quarter 2026 Financial Results and Increases 2026 Revenue Guidance

Caris Life Sciences Raises FY2026 Sales Guidance from $1.000B-$1.020B to $1.030B-$1.040B vs $1.003B Est

Caris Life Sciences: Disrupting Cancer Screening And Therapy Selection

Caris Life Sciences (CAI) Stock Looks Undervalued On A 47% Slump

Caris Life Sciences (CAI) Sets August Results Date, Is The Stock Undervalued?

Caris Life Sciences (CAI) Launches In House PTEN Test After FDA Prostate Cancer Approval

Caris Life Sciences to Report Second Quarter 2026 Financial Results on August 5, 2026